Current Issue - March 2024, Volume 18, Issue No. 1

1. Second Malaysia National Cancer Registry Report 2012-2016. Ministry Of Health Malaysia.; 2019.
2. Grünewald TG, Alonso M, Avnet S, Banito A, Burdach S, Cidre-Aranaz F, et al. Sarcoma treatment in the era of molecular medicine. EMBO Mol Med. 2020; 12(11): e11131. doi: 10.15252/emmm.201911131
3. Aksnes LH, Bauer HC, Jebsen NL, Follerås G, Allert C, Haugen GS, et al. Limb-sparing surgery preserves more function than amputation: a Scandinavian sarcoma group study of 118 patients. J Bone Joint Surg Br. 2008; 90(6): 786-94. doi: 10.1302/0301-620X.90B6.19805
4. Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, et al. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol. 2005; 23(34): 8845-52. doi: 10.1200/JCO.2004.00.5785
5. Grimer RJ. Surgical options for children with osteosarcoma. Lancet Oncol. 2005; 6(2): 85-92. doi: 10.1016/S1470-2045(05)01734-1
6. Weber KL, Randall RL, Grossman S, Parvizi J. Management of lower-extremity bone metastasis. J Bone Joint Surg Am. 2006; 88 Suppl 4: 11-9. doi: 10.2106/JBJS.F.00635
7. Cheung FH. The practicing orthopedic surgeon's guide to managing long bone metastases. Orthop Clin North Am. 2014; 45(1): 109-19. doi: 10.1016/j.ocl.2013.09.003
8. Henderson ER, Groundland JS, Pala E, Dennis JA, Wooten R, Cheong D, et al. Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J Bone Joint Surg Am. 2011; 93(5): 418-29. doi: 10.2106/JBJS.J.00834
9. Veth RP, van Hoesel QG, Bökkerink JP, Hoogenhout J, Pruszczynski M. The art of limb salvage in musculoskeletal oncology. Crit Rev Oncol Hematol. 1995; 21(1-3): 77-103. doi: 10.1016/1040-8428(94)00168-5
10. Henshaw RM. Surgical advances in bone and soft tissue sarcoma: 50 years of progress. Am Soc Clin Oncol Educ Book. 2014: 252-8. doi: 10.14694/EdBook_AM.2014.34.252
11. Yao W, Cai Q, Wang J, Zhang P, Wang X, Du X, et al. Biological reconstruction in the treatment of extremity sarcoma in femur, tibia, and humerus. Medicine (Baltimore). 2020; 99(27): e20715. doi: 10.1097/MD.0000000000020715
12. Errani C, Ceruso M, Donati DM, Manfrini M. Microsurgical reconstruction with vascularized fibula and massive bone allograft for bone tumors. Eur J Orthop Surg Traumatol. 2019; 29(2): 307-11. doi: 10.1007/s00590-018-2360-2
13. Grimer RJ, Aydin BK, Wafa H, Carter SR, Jeys L, Abudu A, et al. Very long-term outcomes after endoprosthetic replacement for malignant tumours of bone. Bone Joint J. 2016; 98-B(6): 857-64. doi: 10.1302/0301-620X.98B6.37417
14. Capanna R, Scoccianti G, Campanacci DA, Beltrami G, De Biase P. Surgical technique: extraarticular knee resection with prosthesis-proximal tibia-extensor apparatus allograft for tumors invading the knee. Clin Orthop Relat Res. 2011; 469(10): 2905-14. doi: 10.1007/s11999-011-1882-2
15. Yasin NF, Abdul Rashid ML, Ajit Singh V. Survival analysis of osteosarcoma patients: A 15-year experience. J Orthop Surg (Hong Kong). 2020; 28(1): 2309499019896662. doi: 10.1177/2309499019896662
16. Capanna R, Scoccianti G, Frenos F, Vilardi A, Beltrami G, Campanacci DA. What was the survival of megaprostheses in lower limb reconstructions after tumor resections? Clin Orthop Relat Res. 2015; 473(3): 820-30. doi: 10.1007/s11999-014-3736-1
17. Jeys LM, Kulkarni A, Grimer RJ, Carter SR, Tillman RM, Abudu A. Endoprosthetic reconstruction for the treatment of musculoskeletal tumors of the appendicular skeleton and pelvis. J Bone Joint Surg Am. 2008; 90(6): 1265-71. doi: 10.2106/JBJS.F.01324
18. Racano A, Pazionis T, Farrokhyar F, Deheshi B, Ghert M. High infection rate outcomes in long-bone tumor surgery with endoprosthetic reconstruction in adults: a systematic review. Clin Orthop Relat Res. 2013; 471(6): 2017-27. doi: 10.1007/s11999-013-2842-9

Abstract   |   Reference